W. H. HITZIG From the Department ofPediatrics, University ofZurich, Switzerland Paediatricians have long been deeply concerned with problems of infection. The sharp decrease in childhood mortality in recent decades in highly developed countries is mainly due to progress in preventing and treating infection: for example, in Switzerland in 1973 there were about 88 000 births and only 16 deaths due to infection in children aged between 2 and 4 years in contrast to 76 killed by accidents. In underdeveloped countries more than 50% of the children die during childhood, infection being a predominant cause.
Individual differences in the ability to cope with pathogens have been assumed for a long time, but were not studied scientifically until the introduction of antibiotics had resulted in control of the major infections. At this time paediatricians began to pay more attention to constitutional and inherited diseases, and made observations on congenital deficiencies of selective defence mechanisms which have contributed to a better understanding of the normal immunological functions.
The basis of the currently used classification of primary immune deficiency diseases is the 'twocomponent concept' (Cooper, Paterson, and Good, 1965; Good and Fisher, 1971) . Its main postulate, the distinction between T and B lymphocytes, is wellknown, and provides a useful workinghypothesis clinically.
Methods of Study
Many methods for measuring immune reactions have been devised in the last two decades. They distinguish between cell-mediated and antibodymediated immune reactions, which correspond almost completely with T-and B-cell-mediated reactions respectively.
Simple in-vivo procedures have been used for many years. Thus, circulating antibodies are detected by an immediate skin reaction after intracutaneous administration of the corresponding antigen. In contrast the cell-mediated reaction needs time to develop; it is therefore a reaction of delayed hypersensitivity. For both tests the patient must be exposed to the antigen, which is not only painful but involves also the danger of hyperergic reactions. Therefore, in-vitro tests are preferable.
CELL-MEDIATED RESPONSES
The simple count of circulating lymphocytes gives one important figure. The size of some lymphoid organs can roughly be estimated by palpation. The thymus can be visualized radiologically, and its histology can be studied if a biopsy is available. Most important, however, are functional methods for measuring the reaction of the lymphocyte to an exogenous antigenic stimulus. The lymphocytes are activated to undergo mitosis, which can be assessed by various methods, most accurately by the measurement of incorporation of precursor substances such as 3H-thymidine into DNA. The stimulus may be homologous cells, specific antigens, or non-specific plant mitogens like phytohaemagglutinin (WHO report, 1970) .
ANTIBODY-MEDIATED RESPONSES
Humoral immune mechanisms can be evaluated by the overall determination of circulating immunoglobulins but more accurately by titration of specific antibodies. When a functional method is used to determine the response to antigenic stimulation, the change in serum antibody titres can be measured as well as the anatomical changes in the lymphoid organs.
In addition to these classical methods, a new principle was introduced two years ago: by chance, a previously well known enzyme, adenosine deaminase (ADA), was shown to be important for immune reactions by observations on patients who had both congenital absence of the enzyme and immune deficiency. It Stiehm and Fulginiti, 1973; Hitzig, 1974) .
The following syndromes are of importance for clinical chemists.
Sex-linked agammaglobulinaemia In 1952 Bruton described a patient with severe widespread infections due to pyogenic organisms, including cutaneous infections with abscess formation, respiratory infections including otitis, sinusitis and severe bronchopneumonia, gastrointestinal infections, and finally blood stream invasion resulting in purulent meningitis and septicaemia. The detection of a complete lack of immunoglobulins gave the name to the disease, and stimulated investigations of the role of immunoglobulins as specific antibodies. The normal antibody response to stimulation by specific antigens is completely absent, and this is in keeping with the morphology of the lymphoid system which shows severe atrophy and absence of germinal centres and plasma cells. In a number of families the heredity of the disease could be demonstrated; the phenotypically healthy mothers transmit the disease only to their sons. This proves that the anomalous gene is located on the X chromosome.
The importance of antibody deficiency in this syndrome is shown by the therapeutic success of the injection of human gamma globulin preparations.
In these patients B lymphocytes are usually absent. In the normal human fetus B cells appear around the eleventh gestational week, ie, long before the actual secretion of specific antibodies. Animal experimentation has clearly demonstrated that the synthesis of the three main immunoglobulin classes is acquired in a rigidly fixed sequence, starting with IgM, proceeding to IgG, and finally followed by IgA (Lawton, Self, Royal, and Cooper, 1972) . This sequence recapitulates the phylogenetic development of antibodies as demonstrated in a large number of different animal species (Good, Finstad, Gewurz, Cooper, and Pallora, 1967) . It must therefore be concluded that in congenital sex-linked agammaglobulinaemia this development is lacking, and several authors claim that the absence of membrane immunoglobulins as markers of B lymphocytes is the most sensitive test for the early diagnosis of this disease.
A few cases, however, were not consistent with this concept, since they had normal membrane immunoglobulin but virtually no circulating immunoglobulins or specific antibodies. It was therefore concluded that in this disease the normal differentiation into functional B cells is blocked, and that the site of the block can vary; in the first instance there is a failure of transition of the primitive stem cell into the B cell, whereas in the second instance the B cells produce immunoglobulins but do not release them.
A recent study of an unusual patient seems to throw some light on the mechanism of this transition (Hitzig and Kenny, 1975 Table II Transport proteins for vitamin B12 which is normally present in concentrations of about 25 ,ug/l plasma. It is necessary for the transport of vitamin B12 from the gut wall to the cells, and probably also for its penetration into the cells. After the administration of large doses (1000 micrograms twice weekly) of vitamin B12 the boy made a spectacular recovery, the blood picture returned to normal, and the gastrointestinal and respiratory infections disappeared (Dohmann, Gimpert, Vischer, Pluss, and Hitzig, 1974) . Gamma globulin injections were continued, but in the course of the next two months it was suspected that he had started to synthesize his own immunoglobulins, since he exhibited very high IgM levels which could not be accounted for by the injected material which consisted almost entirely of IgG. The gamma globulin injections were stopped, and the rise of immunoglobulins continued. In addition, specific antibodies to diphtheria and tetanus appeared, much to our surprise, as although diphtheria and tetanus toxoids 85 had been given with KLH' three times during the first three months of life, no antibodies had appeared previously. Now, six months after the last antigen injection, significant titres appeared, and after a single booster injection these titres rose to very high values within 10 days. To characterize the nature of this antibody response further, the serum samples taken three and 10 days after the booster injection were fractionated in the ultracentrifuge and proved to contain IgG antibodies exclusively (Hitzig and Kenny, 1975) . In this case there is evidence that the lymphoid cells showed normal differentiation initially, since shortly after birth B lymphocytes with all three classes of membrane Igs were present in approximately normal numbers (Cooper, Lawton, and Kincade, 1972) . For these cells to proceed to antibody secretion, however, two conditions are necessary, namely, antigenic stimulation and normal metabolism. In the sterile surroundings in which the boy was nursed during the first months of life, bacterial antigens were excluded, but specific and long-lasting stimulation was provided by sterile toxoids. From other patients reared under sterile conditions we know that antibody formation is perfectly possible, and the failure to produce antibodies in this patient is therefore attributed to an insufficiency of vitamin B12. When B12 was administered, antibody secretion occurred. A booster injection elicited an anamnestic response, thus proving that the first three antigen injections had left an impression on the immunological system with formation of memory cells. We conclude, therefore, that differentiation of these cells had proceeded before birth in the usual way but that clonal expansion and the synthesis and secretion of antibody was dependent on adequate concentrations of vitamin B12. The lymphoid system thus appears to have behaved like the haematopoietic system and the intestinal mucosal epithelium, both of which have rapid cell replication dependent on B12.
Thymic hypoplasia (third and fourth branchial pouch syndrome) In 1968 DiGeorge and Lischner described several children with congenital absence of the thymus and the parathyroids. This defect, which is often combined with other malformations such as hypoplasia of the mandible or aortic arch, is easily explained embryologically as an inhibition of the differentiation of the organs derived from the third and fourth branchial pouch. group.bmj.com on August 15, 2017 -Published by http://jcp.bmj.com/ Downloaded from hypoparathyroidism becomes manifest. Only after appropriate treatment of this life-threatening manifestation do the patients survive and, at a later date, produce the signs of immune deficiency, ie, infections mainly localized in the respiratory system, and the additional signs of a severe cellular immune deficiency, associated with a normal lymphocyte count. Total immunoglobulin levels are normal, but specific antibody formation may be deficient.
Significantly a transplant of fetal thymus almost completely reverses the signs of immune deficiency.
Severe combined immune deficiency The most severe and probably also the most common hereditary immune deficiency syndrome involves both the antibody-and cell-mediated immune mechanisms (Swiss type, thymic alymphoplasia). Accordingly the clinical symptoms and signs are very severe (Hitzig, Barandun, and Cottier, 1968 Before the two-component theory it was suspected that a failure in the development of the thymus was the sole causative factor. When it became known that the antibody-mediated functions were also severely impaired, a separate analogous defect in the development of this system (or in modern terminology, lack of T and B lymphocytes) was postulated. This, however, seems improbable, and a defect of the stem cell from which both chains of lymphocyte develop is a much more logical explanation, and this is accepted by most investigators today. Different genetic forms have been distinguished on purely clinical grounds, namely, autosomal-recessive X-linked and sporadic forms, but the hereditary basis is not clear.
Almost two years ago a new finding threw some light on at least one group of these patients (Giblett, Anderson, Cohen, Pollara, and Meuwissen, 1972) . During the search for genetic markers the absence of adenosine deaminase (ADA) was found in two such patients. The parents of these children showed significantly reduced enzyme activity, and it was considered that they were heterozygous, whereas the children were homozygous for the deficiency. Very little was known about the frequency of this special subgroup of severe combined immune deficiency, and we decided therefore to investigate again all the families of our previously deceased patients. Eight families were available for study, and in three pairs of parents the enzyme deficiency was present. One was a family described previously as an apparently incomplete manifestation of this syndrome (Hitzig, Landolt, Muller, and Bodmer, 1971) . We reviewed, therefore, the data from all our patients and compared them with the findings in the literature. We now suspect that the 'normogammaglobulinaemic antibody deficiency syndrome with severe lymphopenia' might be the clinical counterpart of ADA deficiency. It seemed possible that the Nezelof syndrome, which usually is regarded as a special entity, is also an example of this newly defined deficiency disease. Preliminary estimates indicate a frequency of one quarter to one half of all cases of severe combined immune deficiency.
The following hypothesis has been presented to explain the pathogenesis of the severe combined immune deficiency syndrome: ADA catalyses the critical metabolic step leading from adenosine to inosine. In its absence adenosine monophosphate accumulates and this product has been shown to be toxic to lymphocytes. On The phylogenetically 'young' IgA system is highly developed on mucosal surfaces, and seems to protect them against invasion by microorganisms. It has therefore been called the secretory immunoglobulin system and compared with a mucosal 'antiseptic paint' (Heremans, Crabbe, and Masson, 1966; Tomasi and Bienenstock, 1968) . IgA antibodies have no bacteriostatic or bacteriolytic properties but apparently just coat the surface of bacteria and change their properties in such a way that the adhesion to and subsequent invasion of epithelial cells is greatly inhibited. This provides a very effective protection against bacterial invasion (Williams and Gibbons, 1972 'normal' premature and full-term infants (Pilgrim et al, 1975 (Hitzig, 1971) CONVENTIONAL TREATMENT Patients with constitutional immune deficiencies suffer from recurrent infections or are chronically ill. In some of them symptomatic treatment is 89 effective: congenital sex-linked agammaglobulinaemia can usually be kept under control by regular injections of human gamma globulin (0-3 ml/kg each week or 1.0 ml/kg every three weeks). This replacement treatment has been reviewed extensively. Table IV Therapy with immunoglobulins The real problems arise with cellular immunodeficiencies which are invariably fatal if untreated. To help these patients, exceptional and even heroic therapeutic approaches are necessary.
BONE MARROW TRANSPLANTATION
On the assumption of a stem cell deficiency a considerable number of patients with severe combined immune deficiency have received bone marrow transplants. Last year 25 patients were known to have had replacements and this number has steadily increased since. The greatest danger is graft-versushost reaction which is still difficult to treat. The principles of the procedure are well outlined in a protocol set up by the Society for Experimental Haematology. In the majority of cases, however, no compatible donor is available. It is now evident that in such cases no attempt should be made to transplant incompatible bone marrow. The abovementioned protocol in these cases recommends the use of fetal tissues. (Hitzig and Grob, 1974) , and, owing to the lack of standardization both of the preparation and of the clinical application, we found it very difficult to make a final judgment. It seems that in the Wiskott-Aldrich syndrome it is helpful in about half the patients treated. The most dramatic success has been obtained in patients with chronic mucocutaneous candidiasis, especially the granulomatous form, but even in this condition some failures have been recorded.
Therapeutic trials on patients with congenital immune deficiency have contributed to the basic understanding of physiological immune mechanisms and to the treatment of acquired diseases as well. In particular the knowledge gained from bone marrow transplantation in severe combined immune deficiency has opened the way to similar treatment of patients with leukaemia and aplastic anaemia and may become quite important in the future.
